Dashboard
Manage Tickers

GSK


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle
COVID-19 Patent Dispute Sorted: Acuitas Th...
04/26/2024 18:45:00

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

whats-going-on-with-pfizer-stock-on-thursday
What's Going On With Pfizer Stock On Thurs...
04/25/2024 17:51:32

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...

Core News & Articles
CureVac Has Started The Phase 1 Part Of A ...
04/24/2024 11:20:32

https://www.curevac.com/en/curevac-announces-start-of-combined-phase-1-2-study-in-avian-influenza-h5n1-development-in-collabora...

Core News & Articles
CureVac And GSK Will End The Pandemic Prep...
04/24/2024 11:18:42

the-fda-has-accepted-supplemental-biologics-license-application-for-gsks-jemperli-dostarlimab-in-combination-with-standard-of-care-chemotherapy-to-expand-treatment-to-all-adult-patients-with-primary-advanced-or-recurrent-endometrial-cancer
The FDA Has Accepted Supplemental Biologic...
04/24/2024 10:58:04

Core News & Articles
As Part Of Wave Life Sciences' Ongoing Col...
04/23/2024 14:22:56

GSK has selected the first two programs to advance following achievement of target validation, marking transition to next pha...

Core News & Articles
Sanofi To Pay $100M To Settle Zantac Cance...
04/22/2024 14:31:27

- Bloomberg

brexit-impact-on-drugs---rising-shortages-in-uk-highlight-brexit-challenges
Brexit Impact On Drugs - Rising Shortages ...
04/19/2024 15:39:26

Discover the impact of Brexit on UK drug shortages. Insights from a recent Nuffield Trust study reveal a doubling in shortages ...

once-valued-at-billions-23andmes-ceo-considers-privatization-to-secure-companys-future
Once Valued At Billions, 23andMe's CEO Con...
04/18/2024 16:06:23

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a fo...

gsk-says-its-blockbuster-shingles-vaccine-shows-high-efficacy-even-after-10-years
GSK Says Its Blockbuster Shingles Vaccine ...
04/17/2024 12:06:07

Lasting protection against shingles for adults over 50 with GSK's RZV vaccine. New data from ZOSTER-049 trial reveals over ...

gsks-eagle-1-phase-3-data-show-potential-for-gepotidacin-as-a-new-oral-treatment-option-for-uncomplicated-urogenital-gonorrhea
GSK's EAGLE-1 Phase 3 Data Show Potential ...
04/17/2024 09:32:08

Gepotidacin achieved a 92.6% microbiological success rate and was non-inferior to the leading combination treatment EAGLE-1 ...

gsk-says-new-long-term-data-show-shingrix-continues-to-provide-protection-against-shingles-in-adults-aged-50-and-over-for-more-than-a-decade
GSK Says New Long-Term Data Show Shingrix ...
04/17/2024 09:30:17

wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts' View...
04/11/2024 11:48:46

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

curevac-gsk-partner-release-data-on-influenza-vaccine-study
CureVac, GSK Partner Release Data On Influ...
04/04/2024 16:18:36

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen c...

in-heart-burn-drug-zantacs-litigation-saga-sanofi-nears-settlement-in-major-lawsuit-cluster
In Heart Burn Drug Zantac's Litigation Sag...
04/04/2024 13:16:44

Sanofi reaches a settlement in principle for about 4,000 Zantac lawsuits in the US, excluding Delaware, regarding alleged cance...

Core News & Articles
CureVac Announces Phase 2 Interim Data fro...
04/04/2024 11:07:12

CureVac N.V. (NASDAQ:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines b...

peering-into-gsks-recent-short-interest
Peering Into GSK's Recent Short Interest
03/26/2024 18:00:33

senator-bernie-sanders-applauds-gsks-move-to-cap-inhaler-costs-at-35-per-month
Senator Bernie Sanders Applauds GSK's Move...
03/21/2024 11:17:20

GSK caps asthma and COPD medicine costs at $35/month, effective Jan 1, 2025. Includes Advair, Breo, Ventolin. Follows AstraZene...

Core News & Articles
U.S. CDC Issues Health Alert Network Healt...
03/18/2024 17:54:51

- Reuters

gsk-reveals-new-phase-3-data-for-jemperli-combo-therapy-to-support-expanded-use-approval-for-wider-endometrial-cancer
GSK Reveals New Phase 3 Data For Jemperli ...
03/18/2024 16:17:41

Latest advancements in endometrial cancer treatment with GSK's Jemperli (dostarlimab)! Explore promising overall survival a...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION